PRAXAIR INC 4
4 · PRAXAIR INC · Filed Nov 5, 2013
Insider Transaction Report
Form 4
Breedlove James T
Senior VP, Gen. Counsel & Sec.
Transactions
- Sale
Common Stock
2013-11-04$123.95/sh−2,000$247,892→ 35,614 total
Holdings
- 5,194.358(indirect: By 401(k))
Common Stock
- 44,120
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (44,120 underlying) - 39,300
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (39,300 underlying) - 34,960
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (34,960 underlying) - 37,930
Stock Option (right to buy)
Exercise: $97.84From: 2012-02-22Exp: 2021-02-22→ Common Stock (37,930 underlying) - 36,095
Stock Option (right to buy)
Exercise: $109.68From: 2013-02-28Exp: 2022-02-28→ Common Stock (36,095 underlying) - 29,755
Stock Option (right to buy)
Exercise: $110.58From: 2014-02-26Exp: 2023-02-26→ Common Stock (29,755 underlying) - 1,247.4
Deferred Stock
Exercise: $0.00→ Common Stock (1,247.4 underlying)
Footnotes (7)
- [F1]The $123.946 price reported is the sale price for all shares sold.
- [F2]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- [F3]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
- [F4]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
- [F5]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
- [F6]Conversion to Praxair Common Stock is on a 1-for-1 basis.
- [F7]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.